Matthew Korenberg - 15 Jul 2025 Form 4 Insider Report for LIFECORE BIOMEDICAL, INC. \DE\ (LFCR)

Role
Director
Signature
/s/ Courtney Schuler, Attorney-In-Fact for Matthew Korenberg
Issuer symbol
LFCR
Transactions as of
15 Jul 2025
Transactions value $
$0
Form type
4
Filing time
17 Jul 2025, 16:41:57 UTC
Previous filing
10 Feb 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Korenberg Matthew E Director C/O LIFECORE BIOMEDICAL, INC., 3515 LYMAN BLVD., CHASKA /s/ Courtney Schuler, Attorney-In-Fact for Matthew Korenberg 17 Jul 2025 0001649903

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LFCR Common Stock Award +19,506 +79% 44,060 15 Jul 2025 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis.
F2 Vests on the earlier of the one year anniversary of the date hereof or the date of the annual meeting of stockholders of the Company first held in calendar year 2026 (provided such date is no less than 50 weeks from the date hereof).